Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Startup Island TAIWAN Bridges Tech Hubs, Launching East Coast Biotech Initiative in Boston
      Biotech

      Startup Island TAIWAN Bridges Tech Hubs, Launching East Coast Biotech Initiative in Boston

      July 6, 2026
      Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics
      Biotech

      Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics

      July 5, 2026
      Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™
      Biotech

      Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™

      July 4, 2026
      Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
      Biotech

      Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

      July 3, 2026
      Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
      Biotech

      Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

      July 2, 2026
      Pew Grants Funding to Biomedical Researchers in Latin America
      Biotech

      Pew Grants Funding to Biomedical Researchers in Latin America

      July 1, 2026
      Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million
      Biotech

      Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million

      June 30, 2026
      Positive interim analysis advances Avecho Phase III insomnia program
      Biotech

      Positive interim analysis advances Avecho Phase III insomnia program

      June 29, 2026
      Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
      Biotech

      Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

      June 28, 2026
      Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
      Biotech

      Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

      June 27, 2026
      « 1 … 3 4 5 6 7 … 150 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026